Ernexa Therapeutics Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $18.1M | $35.4M | $23.5M |
| Jun 2022 | $12.1M | $26.9M | $19.4M |
| Sep 2022 | $12.1M | $20.9M | $13.3M |
| Dec 2022 | $10.2M | $22.3M | $11.4M |
| Mar 2023 | $7.7M | $15.1M | $5.4M |
| Jun 2023 | $43.1M | $47.0M | $1.8M |
| Sep 2023 | $48.7M | $52.2M | $4.6M |
| Dec 2023 | $46.9M | $49.1M | $7.6M |
| Mar 2024 | $53.1M | $49.7M | $5.1M |
| Jun 2024 | $55.0M | $46.5M | $2.6M |
| Sep 2024 | $53.1M | $7.7M | $4.3M |
| Dec 2024 | $3.6M | $5.3M | $1.7M |
| Mar 2025 | $11.0M | $5.1M | $1.9M |
| Jun 2025 | $3.1M | $7.6M | $4.3M |
| Sep 2025 | $2.6M | $6.2M | $3.0M |
| Dec 2025 | $3.4M | $5.8M | $1.9M |
| Mar 2026 | $3.7M | $10.5M | $9.2M |
| Jun 2026 | $3.1M | $6.3M | $5.0M |